Glaritus 100IUmL Solution for injection in Pre-filled Pen

Land: Malaysia

Språk: engelsk

Kilde: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Kjøp det nå

Preparatomtale Preparatomtale (SPC)
10-11-2020

Aktiv ingrediens:

Insulin Glargine

Tilgjengelig fra:

SM PHARMACEUTICALS SDN. BHD.

INN (International Name):

Insulin Glargine

Enheter i pakken:

1X3ml Pieces; 5X3ml Pieces

Produsert av:

WOCKHARDT LIMITED (BIOTECH PARK)

Informasjon til brukeren

                                _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
GLARITUS 100 IU/ML SOLUTION FOR INJECTION
GLARITUS 100 IU/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN
Each ml contains Insulin Glargine 100IU
_____________________________________________________________________________________________________________________
_______________________________________________________________________________________________________________
1
WHAT IS IN THIS LEAFLET
1. WHAT GLARITUS IS USED FOR
2.HOW GLARITUS WORKS
3.BEFORE YOU USE GLARITUS
4.HOW TO USE GLARITUS
5.WHILE YOU ARE USING GLARITUS
6.SIDE EFFECTS
7. STORAGE AND DISPOSAL OF GLARITUS
8.PRODUCT DESCRIPTION
9.MANUFACTURER AND PRODUCT REGISTRATION HOLDER
10.DATE OF REVISION WHAT GLARITUS USED FOR
The treatment of type 1 or type 2 diabetes
mellitus patients who require insulin for the
control of hyperglycaemia
.
HOW GLARITUS WORKS
After injection into the subcutaneous tissue,
te acidic solution is neutralised,leading to
formation of microprecipptates from which
small amounts of insulin glargine are
continuously released, providing a
smooth,peakles,predictable
time/concentration profile and a prolonged
duration of action.
This allows once daily dosing to meet a
patient’s basal insulin needs.
BEFORE YOU USE GLARITUS
_WHEN YOU MUST NOT USE IT _
Inform your doctor if you have any problem
listed below, as the doctor will decide
whether you should be started on Glaritus
•
If you have diabetic ketoacidosis_ _
•
In patients with renal impairment,
insulin requirements may be
diminished_ _
•
In
patients
with
severe
hepatic
impairment,
insulin
requirements
may be diminished due to reduced
capacity
for
gluconeogenesis
and
reduced insulin metabolism.
_ _
_ _
_ _
_ _
_ _
_ _
_BEFORE YOU START TO USE IT _
Insulin glargine must not be used in patients
hypersensitive to insulin glargine or any of
its excipients.
_ TAKING OTHER MEDICINES _
A number of substances affect glucose
metabolism and may require insulin dose
adjustment.
Substances that may enhance the blood
glucose lowering effect 
                                
                                Les hele dokumentet
                                
                            

Dokumenter på andre språk

Informasjon til brukeren Informasjon til brukeren malayisk 09-05-2019

Søk varsler relatert til dette produktet